摘要:
nature.com
sci-hub.se 参考文章(12)
Ruchir N Karmali, Natalie M Jones, Aaron D Levine, Tracking and assessing the rise of state-funded stem cell research Nature Biotechnology. ,vol. 28, pp. 1246- 1248 ,(2010) , 10.1038/NBT1210-1246
Timothy Caulfield, Ubaka Ogbogu, Charles Murdoch, Edna Einsiedel, Patents, commercialization and the Canadian stem cell research community. Regenerative Medicine. ,vol. 3, pp. 483- 496 ,(2008) , 10.2217/17460751.3.4.483
John P Walsh, Charlene Cho, Wesley M Cohen, View from the Bench: Patents and Material Transfers Science. ,vol. 309, pp. 2002- 2003 ,(2005) , 10.1126/SCIENCE.1115813
Robert Streiffer, Informed consent and federal funding for stem cell research. Hastings Center Report. ,vol. 38, pp. 40- 47 ,(2008) , 10.1353/HCR.0.0013
D. J. H. Mathews, G. D. Graff, K. Saha, D. E. Winickoff, Access to stem cells and data: persons, property rights, and scientific progress. Science. ,vol. 331, pp. 725- 727 ,(2011) , 10.1126/SCIENCE.1201382
Christopher Thomas Scott, Jennifer B McCormick, Mindy C DeRouen, Jason Owen-Smith, Federal policy and the use of pluripotent stem cells. Nature Methods. ,vol. 7, pp. 866- 867 ,(2010) , 10.1038/NMETH1110-866
Christopher Thomas Scott, Jennifer B McCormick, Jason Owen-Smith, And then there were two: use of hESC lines. Nature Biotechnology. ,vol. 27, pp. 696- 697 ,(2009) , 10.1038/NBT0809-696
Christopher Thomas Scott, Jennifer B. McCormick, Mindy C. DeRouen, Jason Owen-Smith, Democracy derived? new trajectories in pluripotent stem cell research Cell. ,vol. 145, pp. 820- 826 ,(2011) , 10.1016/J.CELL.2011.05.032
Karl Bergman, Gregory D. Graff, The global stem cell patent landscape: implications for efficient technology transfer and commercial development Nature Biotechnology. ,vol. 25, pp. 419- 424 ,(2007) , 10.1038/NBT0407-419
J. A. Thomson, Embryonic Stem Cell Lines Derived from Human Blastocysts Science. ,vol. 282, pp. 1145- 1147 ,(1998) , 10.1126/SCIENCE.282.5391.1145